Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk

By ASPC 2018 Congress on CVD Prevention FEATURING Patrick Moriarty

836 views

August 10, 2018

Comments 2

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

22.1K views

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

20.1K views

Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

15.7K views

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

14.1K views

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

13.6K views

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

14.5K views

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

11.9K views

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

10.7K views

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

ACC 2023 Conference Coverage

J. Saseen

10.3K views

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

10.8K views

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

9.8K views

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

8.5K views

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

7.1K views

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Scripps Health

N. Lepor

5.2K views

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "Go as…

ACC 2022 Conference Coverage

R. Giugliano

6.4K views

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

The Texas Heart Institute

S. Virani

5.5K views

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Piedmont Heart Institute

A. Klein

4.7K views

I Ordered an Lp(a) Level – Now What?

Canadian Collaborative Research Network

M. O'Donoghue

4.3K views

VICTORION-INITIATE – Comparing Inclisiran First to Usual Care in Pat…

Canadian Collaborative Research Network

M. Gupta

159 views

Inside the Studio with Drs. Joseph Rogers and Salim Virani - Current…

The Texas Heart Institute

J. Rogers, S. Virani

119 views

Login

Login

Join VuMedi

Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk

Related Videos

Role of PCSK9 Inhibitors in Diabetes

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Lp(a): When to Measure it and What to Do About it

Role of Coronary Calcification and Risk Stratification

Updated Lipid Guidelines and Therapy

Recent Cholesterol Guidelines and Integration into Clinical Practice

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Lipids Update: Current Guidelines for Lipid Management

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Directions of Cardiology in the Next Decade: 2022-2032

How Do I Reverse Coronary Plaque?

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "Go as…

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

I Ordered an Lp(a) Level – Now What?

VICTORION-INITIATE – Comparing Inclisiran First to Usual Care in Pat…

Inside the Studio with Drs. Joseph Rogers and Salim Virani - Current…